Multimodality Imaging, The Wave of the Future Multidiscipline Attack on a Complex Disease∗ by Crawford, Michael H.
J A C C : C A R D I O V A S C U L A R I M A G I N G V O L . 6 , N O . 9 , 2 0 1 3
ª 2 0 1 3 B Y T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y F O U N D A T I O N I S S N 1 9 3 6 - 8 7 8 X / $ 3 6 . 0 0
P U B L I S H E D B Y E L S E V I E R I N C . h t t p : / / d x . d o i . o r g / 1 0 . 1 0 1 6 / j . j c m g . 2 0 1 3 . 0 6 . 0 0 4E D I T O R I A L C OMM E N T
Multimodality Imaging, The Wave of the Future
Multidiscipline Attack on a Complex Disease*Michael H. Crawford, MDSan Francisco, CaliforniaSystemic lupus erythematosus (SLE) is an autoim-
mune disorder that occurs mainly in young women
and can affect multiple organ systems. The clinical
course of SLE is often one of spontaneous re-
missions and relapses. One of the most feared
complications of SLE is acute neuropsychiatric
disorders because of the profound effect on the pa-
tient and the association with high mortality (1).
These disorders can present as seizures, psychosis,See page 973organic brain syndrome, strokes, and transient
ischemic attacks (TIA) and may result in cumulative
neurocognitive dysfunction. Recognized potential
causes of these syndromes include cerebritis and hy-
percoagulable states such as antiphospholipid anti-
body syndrome and vasculitis (2). SLE is also known
to promote the premature development of athero-
sclerosis, which is a common cause of stroke/TIA
and dementia (3). Recently, attention has focused
on the cardiac valvular abnormalities seen in SLE
and their potential role in acute neuropsychiatric
syndromes (4–7). The paper in this issue of iJACC
by Roldan et al. (8) addresses the complex issue
of the role of Libman-Sacks valve vegetations (LSV)
in neuropsychiatric disease in patients with SLE.
The focus of this study was causation, and the
hypothesis tested was: do LSV cause cerebral events
in patients with SLE? It is very difﬁcult if not
impossible to design a prospective controlled study*Editorials published in JACC: Cardiovascular Imaging reﬂect the views of
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to disclose.to test this hypothesis. Thus, they conducted a
cross-sectional and longitudinal observational study
to observe the relationship between LSV and cere-
bral events in patients with SLE using multi-
modality imaging of the heart, vessels, and brain.
They used transesophageal echocardiography
(TEE) to detect LSV and aortic atherosclerosis;
carotid duplex ultrasound to detect atherosclerosis;
transcranial Doppler ultrasound to detect cerebral
microemboli; and brain magnetic resonance imaging
(MRI) and magnetic resonance angiography to
detect cerebral lesions and intracranial vascular dis-
ease. By showing that LSV was strongly associated
with increased microemboli and brain lesions, their
data supported the hypothesis. Also, the longitudi-
nal follow-up studies showed that regression of LSV
was associated with a decrease in microemboli and
neuropsychiatric disease. In addition, 1 patient who
died following an acute cerebral episode had LSV
and ﬁbrin emboli in their brain vessels. Other po-
tential causes of cerebral emboli or vascular disease
were not associated with the neurological events
studied, such as aortic and carotid atherosclerosis,
brain vessel thrombi, atrial ﬁbrillation, patent fora-
men ovale, left ventricular ejection fraction, blood
pressure, duration of SLE, and speciﬁc drug ther-
apy. Pathological studies support this hypothesis.
Ellis et al. (9) performed post mortem brain exami-
nations on 57 patients with SLE and found that 50%
had brain infarctions with microinfarcts out-
numbering large infarcts (>1 cm) by 3 to 1. Arterial
thrombosis or vasculitis was uncommon (<15%), and
no septic emboli were observed. More than one-half
had evidence of ﬁbrin or platelet emboli. More
recently, Devinsky et al. (10) performed autopsies on
50 patients with SLE and found 10 with cerebral
emboli. Of these 10, 5 had LSV, 2 had valvulitis, and
2 had left ventricular thrombosis. No brain vessel
vasculitis was observed.
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985Some of the strengths of this study involve the
careful and comprehensive analysis of the patients.
Although the number of patients with acute neuro-
psychiatric events was small, they also studied
46 matched control patients with SLE without a
history of neurological events and 26 age- and sex-
matched healthy controls. Considering the exten-
sive testing completed on these 102 participants, the
number is substantial. Because this was a single-
center study, was this a biased sample? Their study
population was drawn from the 1.5 million people
who live in New Mexico because their center sees
almost all of the patients with SLE in the state. The
diagnosis of SLE and neuropsychiatric disease was
evaluated by experts using well-deﬁned clinical
criteria. In addition to the extensive imaging, a large
battery of clinical and laboratory tests were em-
ployed to strengthen their diagnoses, including for-
mal neurocognitive testing. Also, all imaging studies
were evaluated by observers blinded to which group
the patients were in. This study is an excellent
example of how multimodality imaging can be used
to mitigate some of the weaknesses of observational
studies.Many facets of the proposed pathophysiology
of SLE cerebral events were studied, each by one or
more imaging modalities. It is also an outstanding
example of a multidisciplinary approach to studying
a complex problem. The authors included a rheu-
matologist, hematologist, statistician, radiologist,
neurosurgeon, psychologist, bioengineer, and 2 car-
diologists. I believe this study represents a model for
attacking complex problems that do not lend them-
selves to prospective controlled trials.
Does this study establish that LSV causes acute
neuropsychiatric disease in patients with SLE?
Probably not, but the weight of evidence in this
study strongly suggests that emboli from LSV are
causative in some patients, especially young women
with focal neurological events. In this study, the
only strong correlation was with LSV (hazard ratio
[HR]: 5.6). Also, strokes or TIA in general pop-
ulations are more common in older individuals, but
their patients’ average age was <40 years; that is not
to say that in speciﬁc individuals a focal neurological
event was not due to some other cause. Global
neurocognitive dysfunction was highly correlated
with LSV (HR: 8.0), but it was also correlated with
smoking (HR: 3.8) and parameters that measure the
duration and severity of SLE (HR: 1.4 to 2.1).
Thus, it seems more likely that global neuro-
cognitive dysfunction may have several causes alone
or in combination, but LSV with multiple emboli
certainly seems to be one of them, if not the most
frequent cause. Clearly, this study should raiseawareness of the potential pathogenetic role of LSV
in SLE neuropsychiatric syndromes.
Given the potential importance of LSV, should
all patients with SLE have TEE? A previous
randomized controlled study by Roldan’s group
showed that as compared with TEE, transthoracic
echocardiography (TTE) has an 11% sensitivity for
LSV and a negative predictive value of 57% (11).
Thus, TTE may not be adequate to reliably detect
LSV. However, TEE is inconvenient and more
costly and has some risk. If we are going to
recommend TEE, it should have some impact on
therapy choices and ideally improve outcomes. The
authors recommend TEE for patients with SLE
with: 1) acute, recent (<4 weeks) or recurrent
stroke/TIA; or 2) nonfocal neuropsychiatric
symptoms if there is evidence of focal brain lesions
on MRI or cerebral microemboli on transcranial
Doppler. They further assert that this approach
may also be appropriate for other similar condi-
tions such as rheumatoid arthritis (12,13). In their
study, of the 30 patients with neurological syn-
dromes who were treated, 23 survived hospitali-
zation and 18 showed a reduction in LSV, cerebral
microemboli, and MRI brain lesions, with
improvement in neurocognitive function. However,
this was not a treatment study and we do not
know whether the results of the study tests inﬂu-
enced treatment. Although treatment included
anticoagulation and immunosuppression drugs, we
do not know the criteria or indications for speciﬁc
therapies. Consequently, it is difﬁcult to assess the
added beneﬁt of knowing there were LSV.
Patients with SLE and no history of acute
neuropsychiatric disease often have LSV (28% in
this study) and evidence of cerebral microembolism
(20%). Thus, there may be a role for the prophy-
lactic treatment of patients with LSV to prevent
neurological disease. There are no data in this
paper on prophylactic treatment. One difﬁculty
with prophylactic treatment is that Roldan’s group
has previously shown that LSV can come and go
over time without an apparent relationship to
treatment or SLE activity (14). Thus, markers
other than the mere presence of LSV may be
needed to identify the high-risk patient for future
neurological disease. Clearly, as the researchers
acknowledged, studies need to be done to deter-
mine the most appropriate treatment for acute
neuropsychiatric disease in SLE and its prevention.
Until this is known, it is difﬁcult to determine
with certainty who should have TEE.
Infective endocarditis is a well-recognized
complication of SLE valvular disease and can
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986present with similar clinical ﬁndings as acute SLE
neurological disease (15). Treatment with immuno-
suppression and anticoagulants may be inappropriate
for SLE-associated infective endocarditis. TEE is the
mainstay of the diagnosis of infective endocarditis,
but the presence of LSV may confuse the diagnostic
picture. Therefore, greater reliance on blood culture
results may be necessary. Unfortunately, echocardi-
ography is not a goodmethod for determining a tissue
diagnosis (infective vegetation vs. LSV). Although
certain echocardiographic features of each disease are
helpful in making the distinction (e.g., paravalvular
abscess), diagnostic certainty is often lacking. This
problem is highlighted in this study by the detection
of LSV in 2 of the healthy controls (8%). The nature
and cause of these lesions is questionable and their
clinical signiﬁcance is problematic.Thus, until the appropriate therapy for LSV and
the factors that inﬂuence the speciﬁcity of TEE for
LSV are better understood, it seems premature to
recommend TEE widely in patients with SLE. On
the other hand, this comprehensive multidisci-
plinary, multimodality imaging study clearly showed
that LSV is an important feature of acute neuro-
psychiatric disease in SLE, and knowledge of their
existence could inﬂuence treatment in selected pa-
tients. I hope that Roldan and his colleagues
continue to study the important issues raised by
their landmark paper.
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